Compare Stocks: CNA, GLO, AMPH, and OPG

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMPH Amphastar Pharmaceuticals	$23.62	$21.29	$16.65 ▼ $29.52	$1.00B	0.92	438,390 shs	1.45 million shs
CNA CNA Financial	$47.98 -0.1%	$50.53	$41.53 ▼ $55.71	$12.99B	0.27	440,191 shs	1.08 million shs
GLO Clough Global Opportunities Fund	$5.44	$5.80	$5.39 ▼ $6.18	N/A	N/A	162,110 shs	242,902 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMPH Amphastar Pharmaceuticals	0.00%	-0.67%	+9.35%	+28.86%	-14.54%
CNA CNA Financial	0.00%	+0.64%	-2.24%	+4.63%	+4.99%
GLO Clough Global Opportunities Fund	0.00%	-3.20%	-6.21%	-9.18%	-4.90%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMPH Amphastar Pharmaceuticals	$23.62	$21.29	$16.65 ▼ $29.52	$1.00B	0.92	438,390 shs	1.45 million shs
CNA CNA Financial	$47.98 -0.1%	$50.53	$41.53 ▼ $55.71	$12.99B	0.27	440,191 shs	1.08 million shs
GLO Clough Global Opportunities Fund	$5.44	$5.80	$5.39 ▼ $6.18	N/A	N/A	162,110 shs	242,902 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMPH Amphastar Pharmaceuticals	0.00%	-0.67%	+9.35%	+28.86%	-14.54%
CNA CNA Financial	0.00%	+0.64%	-2.24%	+4.63%	+4.99%
GLO Clough Global Opportunities Fund	0.00%	-3.20%	-6.21%	-9.18%	-4.90%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMPH Amphastar Pharmaceuticals	1.75	Reduce	$22.50	-4.74% Downside
CNA CNA Financial	2.50	Moderate Buy	N/A	N/A
GLO Clough Global Opportunities Fund	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest CNA, GLO, AMPH, and OPG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2026	AMPH Amphastar Pharmaceuticals	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$20.00 ➝ $23.00
8/7/2026	AMPH Amphastar Pharmaceuticals	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$21.00 ➝ $20.00
8/7/2026	AMPH Amphastar Pharmaceuticals	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$19.00 ➝ $20.00
7/21/2026	AMPH Amphastar Pharmaceuticals	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/17/2026	CNA CNA Financial	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B-) ➝ Buy (B)
7/16/2026	CNA CNA Financial	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/8/2026	AMPH Amphastar Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
6/30/2026	CNA CNA Financial	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
6/29/2026	AMPH Amphastar Pharmaceuticals	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral ➝ Underperform	$25.00 ➝ $20.00
6/22/2026	AMPH Amphastar Pharmaceuticals	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell

(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMPH Amphastar Pharmaceuticals	$719.89M	1.40	$4.26 per share	5.55	$17.17 per share	1.38
CNA CNA Financial	$14.86B	0.87	$4.44 per share	10.80	$42.94 per share	1.12
GLO Clough Global Opportunities Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMPH Amphastar Pharmaceuticals	$98.09M	$1.69	13.98	9.12	4.55	10.76%	14.98%	6.96%	11/5/2026 (Estimated)
CNA CNA Financial	$1.28B	$4.55	10.54	10.04	6.41	8.16%	11.34%	1.84%	11/2/2026 (Estimated)
GLO Clough Global Opportunities Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest CNA, GLO, AMPH, and OPG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2026	Q2 2026	AMPH Amphastar Pharmaceuticals	$0.62	$0.91	+$0.29	$0.67	$179.92 million	$183.90 million
8/3/2026	Q2 2026	CNA CNA Financial	$1.08	$1.19	+$0.11	$1.18	$2.97 billion	$3.83 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMPH Amphastar Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
CNA CNA Financial	$1.92	4.00%	+1.99%	42.20%	9 Years
GLO Clough Global Opportunities Fund	$1.22	22.43%	N/A	N/A	N/A

Latest CNA, GLO, AMPH, and OPG Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/7/2026	GLO Clough Global Opportunities Fund	monthly	$0.0537	11.78%	9/17/2026	9/17/2026	9/30/2026
8/3/2026	CNA CNA Financial	quarterly	$0.48	3.84%	8/17/2026	8/17/2026	9/3/2026
7/7/2026	GLO Clough Global Opportunities Fund	monthly	$0.0537	10.85%	8/18/2026	8/18/2026	8/31/2026
7/7/2026	GLO Clough Global Opportunities Fund	monthly	$0.0537	10.94%	7/17/2026	7/17/2026	7/31/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMPH Amphastar Pharmaceuticals	0.79	2.40	1.71
CNA CNA Financial	0.27	0.27	0.27
GLO Clough Global Opportunities Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMPH Amphastar Pharmaceuticals	65.09%
CNA CNA Financial	98.45%
GLO Clough Global Opportunities Fund	N/A

Insider Ownership

Company	Insider Ownership
AMPH Amphastar Pharmaceuticals	29.60%
CNA CNA Financial	0.29%
GLO Clough Global Opportunities Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMPH Amphastar Pharmaceuticals	1,976	42.54 million	29.95 million	Optionable
CNA CNA Financial	6,600	270.60 million	269.82 million	Optionable
GLO Clough Global Opportunities Fund	N/A	N/A	N/A	Not Optionable

CNA, GLO, AMPH, and OPG Headlines

Recent News About These Companies

Clough Global Opportunities Fund Section 19(a) Notice

August 31, 2026 | accessnewswire.comA

Clough Global Opportunities Fund Section 19(a) Notice

July 31, 2026 | accessnewswire.comA

Clough Global Opportunities Fund | GLO: Clough Global Opportunities Fund Declares Monthly Distributions for July, August, and September 2026 of $0.0537 Per Share

July 7, 2026 | finanznachrichten.de

Clough Global Opportunities Fund declares $0.0537 dividend

July 7, 2026 | seekingalpha.com

Clough Global Opportunities Fund Declares Monthly Distributions for July, August, and September 2026 of $0.0537 Per Share

July 7, 2026 | accessnewswire.comA

Clough Global Opportunities Fund Section 19(a) Notice

June 30, 2026 | accessnewswire.comA

Clough Global Opportunities Fund Renews Share Repurchase Program

June 12, 2026 | tipranks.com

Clough Global Closed-End Funds: Clough Closed-End Funds Announce Renewal of Share Repurchase Programs

June 12, 2026 | finanznachrichten.de

Clough Global Opportunities Fund

May 29, 2026 | cnbc.com

Clough Global Opportunities Fund Section 19(a) Notice

May 29, 2026 | accessnewswire.comA

Clough Global Opportunities Fund Section 19(a) Notice

April 30, 2026 | accessnewswire.comA

Clough Global Dividend and Income Fund | GLV: Clough Global Dividend and Income Fund Declares Monthly Distributions for April, May, and June 2026 of $0.0566 Per Share

April 7, 2026 | finanznachrichten.de

Clough Global Equity Fund | GLQ: Clough Global Equity Fund Declares Monthly Distributions for April, May, and June 2026 of $0.0729 per Share

April 7, 2026 | finanznachrichten.de

Clough Global Opportunities Fund | GLO: Clough Global Opportunities Fund Declares Monthly Distributions for April, May, and June 2026 of $0.0537 Per Share

April 7, 2026 | finanznachrichten.de

Clough Global Opportunities Fund Declares Monthly Distributions for April, May, and June 2026 of $0.0537 Per Share

April 7, 2026 | accessnewswire.comA

Clough Global Opportunities Fund Section 19(a) Notice

March 31, 2026 | accessnewswire.comA

GLO: Generous Dividend Is Hurting Performance

March 11, 2026 | seekingalpha.com

Clough Global Opportunities Fund Section 19(a) Notice

February 27, 2026 | accessnewswire.comA

Clough Global Opportunities Fund Section 19(a) Notice Statement

January 30, 2026 | accessnewswire.comA

Clough Global Opportunities Fund | GLO: Clough Global Opportunities Fund Declares Monthly Distributions For Q1 2026, Increasing Its Distribution By 7.2% To $0.0537 Per Share ...

January 8, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CNA, GLO, AMPH, and OPG Company Descriptions

Amphastar Pharmaceuticals NASDAQ:AMPH

$23.62 0.00 (0.00%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$23.47 -0.15 (-0.65%)

As of 08:51 AM Eastern

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

CNA Financial NYSE:CNA

$47.98 -0.04 (-0.09%)

Closing price 09/18/2026 03:59 PM Eastern

Extended Trading

$48.03 +0.05 (+0.11%)

As of 08:35 AM Eastern

CNA Financial Corporation provides commercial property and casualty insurance products in the United States and internationally. It operates through Specialty, Commercial, International, Life & Group, and Corporate & Other segments. The company offers professional liability coverages and risk management services to various professional firms, including architects, real estate agents, and accounting and law firms; directors and officers, employment practices, fiduciary, and fidelity and cyber coverages to small and mid-size firms, public and privately held firms, and not-for-profit organizations; professional and general liability, as well as associated casualty coverages for healthcare industry; surety and fidelity bonds; and warranty and alternative risks products. It also provides property, marine, boiler, and machinery coverage insurance products; casualty insurance products comprising workers' compensation, general and product liability, commercial auto, umbrella, and excess and surplus coverages; specialized loss-sensitive insurance programs and total risk management services; and run-off long term care policies. The company was founded in 1853 and is based in Chicago, Illinois. CNA Financial Corporation operates as a subsidiary of Loews Corporation.

Clough Global Opportunities Fund NYSEAMERICAN:GLO

$5.44 0.00 (0.00%)

Closing price 09/18/2026 04:10 PM Eastern

Extended Trading

$5.53 +0.09 (+1.62%)

As of 09:02 AM Eastern

Clough Global Opportunities Fund is a closed ended balanced mutual fund launched and managed by Clough Capital Partners L.P. It invests in public equity and fixed income markets across the globe. The fund invests in securities of companies operating across diversified sectors. For its fixed income portion, the fund invests in both investment grade and non-investment grade issues. It employs a combination of fundamental and quantitative analysis with bottom-up stock picking approach to create its portfolio. Clough Global Opportunities Fund was formed on January 12, 2006 and is domiciled in the United States.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CNA, GLO, AMPH, and OPG Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CNA, GLO, AMPH, and OPG Earnings

Compare Dividends

Latest CNA, GLO, AMPH, and OPG Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CNA, GLO, AMPH, and OPG Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CNA, GLO, AMPH, and OPG Company Descriptions

Amphastar Pharmaceuticals NASDAQ:AMPH

CNA Financial NYSE:CNA

Clough Global Opportunities Fund NYSEAMERICAN:GLO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CNA, GLO, AMPH, and OPG Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CNA, GLO, AMPH, and OPG Earnings

Compare Dividends

Latest CNA, GLO, AMPH, and OPG Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CNA, GLO, AMPH, and OPG Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CNA, GLO, AMPH, and OPG Company Descriptions

Amphastar Pharmaceuticals NASDAQ:AMPH

CNA Financial NYSE:CNA

Clough Global Opportunities Fund NYSEAMERICAN:GLO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools